Discover the 12 systems every growing practice needs for medical spa management, from scheduling to compliance, in one connected platform
Another imminent problem is that the GLP-1RAs that are currently used in the clinical setting are biological macromolecular peptide preparations, such as exenatide and liraglutide, with high production costs that limit their clinical application (231)
These physicians will evaluate your unique medical history, biology, and insurance coverage to determine the best treatment plan for you
Splitting, chewing, or crushing the tablet also breaks down this barrier, making the drug less effective
However, this model has several limitations
Coverage remains restricted primarily due to: High price tags: The list price for these medications remains high